Grants and Contributions:
Title:
2425-HQ-000033
Agreement Number:
2425-HQ-000033
Agreement Value:
$32,342,785.00
Agreement Date:
Dec 19, 2024 - Mar 31, 2027
Description:
To provide funding to willing jurisdictions to support improving access for patients with rare diseases to drugs for rare diseases, as well as improving and broadening rare disease treatments and services, to achieve better health outcomes.
Organization:
Health Canada
Expected Results:
Improved collaboration across provincial/territorial drug plans related to drugs for rare decisions decision-making.
Canadians with rare diseases have better access to screening and diagnostic services they need.
Location:
Fredericton, New Brunswick, CA E3B 5G8
Reference Number:
271-2025-2026-Q1-00024
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Type:
Government
Additional Information:
The total agreement value previously disclosed has been updated to reflect a decrease resulting from this amendment.
Amendment Date
May 2, 2025
Recipient's Legal Name:
Government of New Brunswick - Department of Health
Program:
National Strategy for Drugs for Rare Diseases Program
Program Purpose:
Canadian Health Systems and Programs
Amendments: